Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Centogene Q3 Revenues Decrease 13 Percent Due to Non-Recurring Payments From Pharma Partners

Centogene Q3 Revenues Decrease 13 Percent Due to Non-Recurring Payments From Pharma Partners

Dec 05, 2019
|
staff reporter

NEW YORK – German rare disease company Centogene on Thursday reported a 13 percent year-over-year revenue decrease in Q3 caused mainly by non-recurring upfront payments by two pharmaceutical partners a year ago.

"We're driving solid performance that is much better than what it might appear on paper," said Centogene CEO Arndt Rolfs during a conference call to discuss the financial results.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Earlier in the US

An analysis of blood donations suggests SARS-CoV-2 was present in the US weeks earlier than thought, according to NPR.

How the Proteins Shape Up

The Guardian reports that DeepMind Technologies' AlphaFold can predict how proteins fold.

Who's to Be First?

CNBC reports that a US Centers for Disease Control and Prevention advisory panel is to vote on how to distribute COVID-19 vaccines.

PNAS Papers on Ovarian Cancer, Retrotransposon Insertions in Cancer, Malaria Mosquitoes

In PNAS this week: targeting progesterone signaling in ovarian cancer, LINE-1 retrotransposition events in adenocarcinomas, and more.

Dec
03
Featured Webinar

Leveraging Multi-Omic Approaches to Understand Disease Stem Cells in Myeloid Malignancies

Sponsored by
Mission Bio

Recent work by many investigators has discovered that over the course of aging, hematopoietic stem cells (HSCs) commonly undergo clonal expansion. 

What's Popular?

In Molecular Diagnostics

  1. Thermo Fisher Scientific Raises Q4 and 2020 Revenue, Earnings Guidance

  2. Illumina, PierianDx Expand Partnership on Cancer Panel Test Reporting

  3. Cepheid, Roche Coronavirus Tests Get FDA Emergency Use Authorization

  4. UnitedHealthcare to Cover NIPT for Average-Risk Pregnancies

  5. Progenity to Raise $100M in Separate Public Stock, Private Senior Notes Offerings

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.